Microfluidic Cell Deformability Assay for Rapid and Efficient Kinase Screening with the CRISPR-Cas9 System

Xin Han1,2, Zongbin Liu1,2, Li Zhao3

  • 1Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.

Summary

This study used CRISPR-Cas9 gene editing and microfluidics to screen for kinases controlling cancer cell deformability and invasion. Loss of specific kinases increased cell flexibility and metastatic potential, identifying key regulators of tumor suppression.

Related Concept Videos